Some aspects of adherence to combined hormonal contraception in young women

   Introduction. In addition to being protective against unwanted pregnancies, combined hormonal contraceptives (CHCs) can improve health and quality of life of women. The awareness of Russian women about CHCs is 85 %, however, only 13 % of women in Russia have a long-term experience with CHCs. This is why, it is essential to analyse drivers of adherence of young women to CHCs, and the reasons for refusal of them.
   Aim. Identification of the reasons affecting adherence to СHС in young women.
   Materials and methods. Group 1 consisted of 36 women who have tried using СHС, but stopped taking: 1A (19 women) – up to 1 year, 1B (17 women) – from 1 to 3 years; group 2 – 35 women who have never used СHС.
   Results. The level of education in group 2 was significantly lower, patients with secondary general education prevailed. Despite the high awareness of the benefits of СHС, the number of real users of these drugs was only 50.7 %, while half of them used CHС for 9 months on average. The refusal to use СHС in group 2 was motivated by the possible development of side effects, the lack of need for regular contraception, which requires improvement of counseling on using СHС, taking into account the characteristics of the contingent of patients. The reason for the rejection of СHС in groups 1A and 1B, regardless of the duration of use, was side effects in 42.1 and 47.1 % of cases, respectively, which included: headaches, decreased libido; nausea, epigastric pain, intermenstrual spotting, weight gain, emotional lability.
   Conclusion. Taking into account the level of education of patients and their needs, high-quality structured counseling when choosing a method of contraception will increase compliance with the use of СHСs, increase the frequency and duration of using СHСs.

1. Дикке Г. Б. Потребности, ожидания и сомнения у пользователей гормональными контрацептивами / Г. Б. Дикке // Гинекология. – 2020. – 22 (1): 33–37. http://doi.org/10.26442/20795696.2020.1.200044. – Dikke G. B. Needs, expectations and doubt users of hormonal contraceptives. Gynecology. 2020; 22 (1): 33–37. (In Russ.) http://doi.org/10.26442/20795696.2020.1.200044.

2. Дикке Г. Б. Контрацепция и тромбозы. Пути снижения тромботического риска у женщин, применяющих КОК / Г. Б. Дикке, А. В. Соловьева, В. Е. Радзинский ; под ред. В. Е. Радзинского. – М.: StatusPraesens, 2016. – 16 с. – Dikke G. B., Solovyeva A. V., Radzinsky V. E. (eds.). Contraception and thrombo­sis. Ways to reduce thrombotic risk in women using COCs. Moscow: Status Praesens; 2016. 16 p. (In Russ.)

3. Унанян А. Л. Неконтрацептивные эффекты комбинированных оральных контрацептивов: преимущества и риски применения / А. Л. Унанян [и др.] // Гинекология. – 2017. – 19 (2): 69–74. Режим доступа: https://gynecology.orscience.ru/2079-5831/article/view/28638. – Unanyan A. L., Nikonets A. D., Aminova L. N., Alimov V. A., Chushkov Yu. V., Shchukina A. V. et al. Noncontraceptive effects of combined oral contraceptives: benefits and risks of use. Gynecology. 2017; 19 (2): 69–74. (In Russ.) Available at: https://gynecology.orscience.ru/2079-5831/article/view/28638.

4. Хамошина М. Б. Сбывшиеся мечты: как мы ими распоряжаемся? Результаты социологического опроса россиян о знаниях по контрацепции / М. Б. Хамошина, С. А. Маклецова // StatusPraesens. Гинекология, акушерство, бесплодный брак. – 2015. – (5): 43–50. Режим доступа: https://praesens.ru/files/2015/magazine/SP_28.pdf. – Khamoshina M. B., Маklecova S.A. Dreams come true: how do we manage them? Results of a sociological survey of Russians on knowledge of contraception. Status Praesens. Gynecology, Obstetrics, Infertile Marriage. 2015; (5): 43–50. (In Russ.) Available at: https://praesens.ru/files/2015/magazine/SP_28.pdf.

5. Набиева Л. В. Современные проблемы гормональной контрацепции / Л. В. Набиева, Н. В. Григорьева, Г. А. Василькова // Вестник совета молодых ученых и специалистов Челябинской области. – 2019. – (2-1): 43–47. Режим доступа: https://drive.google.com/file/d/1ephwfIJ9OskV2JHMXr8kh7PY8T1IAMxX/view. – Nabieva L. V., Grigorieva V. V., Vasilkova G. A. Modern problems of hormonal contraception. Bulletin of the Council of Young Scientists and Specialists of the Chelyabinsk Region. 2019; (2-1): 43–47. (In Russ.) Available at: https://drive.google.com/file/d/1ephwfIJ9OskV2JHMXr8kh7PY8T1IAMxX/view.

6. Кузнецова И. В. Комбинированная оральная контрацепция. Есть ли ресурс расширения использования? / И. В. Кузнецова, Л. В. Евсюкова, В. А. Коновалов // Медицинский совет. – 2018. – (12): 146–151. https://doi.org/10.21518/2079-701X-2018-12-146-151. – Kuznetsova I. V., Evsyukova L. V., Konovalov V. A. Combined oral contraception: is there a resource for increased use? Meditsinskiy Sovet. 2018; (12): 146–151. (In Russ.) https://doi.org/10.21518/2079-701X-2018-12-146-151.

7. Пруд В. А. Гормональная контрацепция как один из самых эффективных и популярных методов предохранения от нежелательной беременности / В. А. Пруд // Репродуктивное здоровье детей и подростков. – 2016. – (1): 44–52. Режим доступа: https://child-reprodhealth.ru/ru/jarticles_repr/442.html?SSr=020134893d21ffffffff27c__07e6021515021e-37a9. – Prud V. A. Hormonal contraception as one of the most effective and popular methods of preventing unwanted pregnancy. Pediatric and Adolescent Reproductive Health. 2016; (1): 44–52. (In Russ.) Available at: https://child-reprodhealth.ru/ru/jarticles_repr/442.html?SSr=020134893d21ffffffff27c__07e6021515021e-37a9.

8. Чечулина О. В. Персонифицированный подход к выбору метода контрацепции /О. В. Чечулина, О. В. Данилова // Практическая медицина. – 2018. – 16 (9): 40–42. Режим доступа: https://www.yumpu.com/xx/embed/view/z4TlfUHS23jDB0Ec. – Chechulina O. V., Danilova O. V. Personalized approach to the choice of contraceptive method. Practical Medicine. 2018; 16 (9): 40–42. (In Russ.) Available at: https://www.yumpu.com/xx/embed/view/z4TlfUHS23jDB0Ec.

9. Олина А. А. Гормональная контрацепция: алгоритм выбора / А. А. Олина, Т. А. Метелева // РМЖ. Мать и дитя. – 2019. – 2 (2): 76–82. https://www.rmj.ru/articles/ginekologiya/Gormonalynaya_kontracepciya_algoritm_vybora. – Olina A. A., Meteleva T. A. Hormonal contraception: choice algorithm. Russian Journal of Woman and Child Health. 2019; 2 (2): 76–82. (In Russ.) https://www.rmj.ru/articles/ginekologiya/Gormonalynaya_kontracepciya_algoritm_vybora.

10. Дикке Г. Б. Как уменьшить количество побочных эффектов КОК и повысить приверженность к ним: простые советы практическим врачам / Г. Б. Дикке // Медицинский совет. – 2016. – (2): 10–13. https://doi.org/10.21518/2079-701X-2016-2-10-13. – Dikke G. B. How to reduce the number of side effects produced by COCs and improve adherence: simple tips for practitioners. Meditsinskiy Sovet. 2016; (2): 10–13. (In Russ.) https://doi.org/10.21518/2079-701X-2016-2-10-13.

11. Archer D. F., Maheux R., Del Conte A., O’Brien F. B. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG). Am J Obstet Gynecol. 1999; 181 (5 Pt 2): 39–44. https://doi.org/10.1016/s0002-9378(99)70362-5.

12. Wiegratz I., Kuhl H. Metabolic and clinical effects of progestogens. Eur J Contracept Reprod Health Care. 2006; 11 (3): 153–161. https://doi.org/10.1080/13625180600772741.

13. Lidegaard O., Nielsen L. H., Skovlund C. W., Løkkegaard E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ. 2012; 344: e2990. https://doi.org/10.1136/bmj.e2990.

14. Korver T., Klipping C., Heger-Mahn D., Duijkers I., van Osta G., Dieben T. Maintenance of ovulation inhibition with the 75-microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12-h delays in tablet intake. Contraception. 2005; 71 (1): 8–13. https://doi.org/10.1016/j.contraception.2004.07.016.

15. Burke A. Nomegestrol acetate-17b-estradiol for oral contraception. Patient Prefer Adherence. 2013; 7: 607–619. https://doi.org/10.2147/PPA.S39371.

16. Ruan X., Seeger H., Mueck A. O. The pharmacology of nomegestrol acetate. Maturitas. 2012; 71 (4): 345–353. https://doi.org/10.1016/j.maturitas.2012.01.007.